ROCCA, ANDREA

ROCCA, ANDREA  

Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute  

Ricercatori a tempo determinato  

Mostra records
Risultati 1 - 20 di 119 (tempo di esecuzione: 0.049 secondi).
Titolo Data di pubblicazione Autori File
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 1-gen-2023 Balduit, AndreaVidergar, RomanaZacchi, PaolaMangogna, AlessandroAgostinis, ChiaraBottin, CristinaSalton, FrancescoConfalonieri, PaolaRocca, AndreaZanconati, FabrizioConfalonieri, MarcoBulla, Roberta +
[Prophylaxis of toxic effects on the peripheral venous system associated with intravenous administration of vinorelbine] 1-gen-1999 Rocca, A +
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study 1-gen-2019 Rocca, Andrea +
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemo-immunotherapy in patients with advanced melanoma 1-gen-2009 Rocca A +
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer 1-gen-2010 Rocca A +
A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer 1-gen-2015 Rocca, Andrea +
A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancer 1-gen-2006 Rocca, A +
A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer 1-gen-2006 Rocca A +
A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy 1-gen-2005 Rocca, A +
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 1-gen-2024 Salton, FRispoli, MConfalonieri, PDe Nes, ASalotti, ARuaro, BHarari, SRocca, AD'Onofrio, AManzoni, LConfalonieri, M +
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 1-gen-2023 Sobhani, NavidAldegheri, GiovanniRocca, AndreaGiudici, FabiolaBottin, CristinaZanconati, FabrizioGenerali, Daniele +
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy 1-gen-2017 Rocca, Andrea +
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 1-gen-2018 Rocca, Andrea +
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? 1-gen-2018 Rocca, Andrea +
Androgen receptor signaling pathways as a target for breast cancer treatment 1-gen-2016 Rocca, Andrea +
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial 1-gen-2018 Rocca, Andrea +
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study 1-gen-2016 Rocca, Andrea +
Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype 1-gen-2005 Rocca A +
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 1-gen-2020 Rocca, Andrea +
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 1-gen-2018 Rocca, Andrea +